64x Bio develops a high throughput genome engineering platform that accelerates the discovery of optimized mammalian cell lines for cell and gene therapies. This technology enables pharmaceutical and biotechnology companies to efficiently design and manufacture next-generation therapeutics, addressing the challenges of traditional cell line development.

ALICE is an AI‑powered construction optioneering platform that automates generative scheduling and rapid "what‑if" scenario simulation. By uploading existing schedules and design models, users can explore millions of construction sequences, evaluate cost, time and resource impacts, and select optimal plans within minutes, helping owners, developers and contractors reduce risk, improve efficiency, and increase profitability.

Amplifier Therapeutics develops orally administered, peripherally restricted small‑molecule activators of AMP‑activated protein kinase (AMPK) that also boost mitochondrial function. Their lead candidate, ATX‑304, restores cellular energy sensing to increase fatty‑acid oxidation, glucose utilization, and mitochondrial respiration, showing preclinical efficacy in obesity, fatty‑liver disease, diabetes, and acute kidney injury, and is now in a Phase 1B trial. The platform targets pharmaceutical partners and research groups seeking metabolic and age‑related disease therapies.

Astonishing Labs partners with university lab scientists to commercialize groundbreaking biotech research that utilizes electrical signaling for organ growth and cancer treatment without genetic intervention. This approach addresses the slow progress in transforming early-stage scientific discoveries into viable biotech companies, aiming to create therapies with broad implications for various diseases.

Atai Life Sciences is a clinical-stage biopharmaceutical company developing novel therapeutics for mental health conditions. They are advancing psychedelic and non-psychedelic compounds, including DMT, MDMA, and psilocin, to offer rapid-acting and durable relief for patients with treatment-resistant depression, social anxiety disorder, and cognitive impairment.

Beeflow provides end‑to‑end pollination programs for commercial fruit and nut growers, using data‑driven hive placement, real‑time weather monitoring, and specialized bee nutrition to maximize bee activity on target flowers. The platform delivers analytics and forecasts that help growers increase pollination hours, fruit set, and overall harvest quality.

Cambrian Bio is a clinical-stage drug development company focused on creating therapeutics that target the biological mechanisms of aging to prevent chronic diseases. By collaborating with leading scientists, Cambrian aims to develop effective and safe therapies that extend healthspan and improve patient outcomes.

Centivax develops broad-spectrum vaccines aimed at preventing infectious diseases across different species. Their current focus is on a universal influenza vaccine currently in pre-clinical development for ferrets and pigs. The company seeks to advance global health by creating preventative measures against widespread pathogens.

Copernic designs novel heterogeneous catalysts for zero-carbon fuels and chemicals, leveraging scientific computing tools to accelerate development. The company focuses initially on reducing the cost of zero-carbon ammonia production for fertilizers and maritime energy applications. Their solutions are engineered to be economic, rapidly scaleable, and compatible with existing chemical industry infrastructure.

The startup offers a digital collectibles platform built on the Ethereum blockchain, utilizing smart contract technology to ensure secure and transparent transactions. This platform facilitates charitable fundraising by providing a global and perpetual solution for supporting philanthropic causes through unique digital assets.

This entity focuses on advancing AI through rigorous science, particularly in the areas of Large Language Models (LLMs) and generative AI. They develop and release open-source technologies like DBRX and MPT models, alongside tools for efficient deep learning training and evaluation. The work aims to provide high-quality, commercially usable models and performance optimizations for the AI community.

Deep Genomics utilizes a proprietary AI platform to analyze complex RNA biology data, identifying novel therapeutic targets for genetic conditions. By streamlining the drug discovery process, the company aims to develop RNA therapies that can precisely target genetic causes, significantly reducing the time and cost associated with traditional methods.

Earthshot Labs develops and finances nature-based carbon projects by integrating scientific rigor with next-generation technology for greenhouse gas accounting. The company supports land stewards globally to create and monetize conservation and reforestation efforts within carbon markets. This process transforms natural assets into an investable asset class, enabling impactful financing for community-led interventions.

Enriched Ag utilizes artificial intelligence and satellite imagery to monitor agricultural health, focusing on soil conservation, forage production, and animal well-being. The platform provides actionable insights that enhance productivity and profitability while addressing challenges such as invasive species management and resource allocation on farms and ranches.

Faeth Therapeutics utilizes computational biology and machine learning to develop multi-nodal nutritional treatments that target cancer metabolism, inhibiting cell growth through a comprehensive understanding of metabolic pathways. This approach addresses the limitations of traditional therapies by expanding the range of druggable targets within the cancer metabolism landscape.

Gameto is a biotechnology company utilizing cell engineering to develop therapeutics for women's reproductive health, focusing on improving in vitro fertilization (IVF) and egg freezing processes. The company addresses significant gaps in fertility treatments and aims to enhance patient outcomes through its innovative platform.

Glass Imaging provides AI-powered Neural Image Signal Processing that corrects lens aberrations and sensor defects in raw sensor data, delivering DSLR‑level image and video quality on size‑, weight‑, and power‑constrained devices. Its technology includes Neural Zoom for high‑detail multi‑frame zoom, Neural Night for extreme low‑light denoising, and co‑designed optics that increase light capture, all deployable on edge‑AI compute platforms for smartphone, drone, and other compact camera manufacturers.

GreenLight Biosciences produces RNA‑interference (RNAi) biopesticides that silence target genes in insects, fungi, and weeds, delivering species‑level specificity with rapid environmental degradation and no residue on crops. Their scalable manufacturing platform creates commercial‑grade foliar sprays compatible with standard farm equipment, offering growers a residue‑free, EPA‑approved alternative to conventional chemicals.

Hephae Energy Technology develops the Pandora210, a high-temperature directional drilling system that enables the efficient drilling of geothermal wells in superhot rock formations. This technology addresses the high costs and limitations of traditional geothermal drilling methods, making geothermal energy more economically viable and scalable.

The startup offers a capital funding platform that utilizes artificial intelligence to analyze financial data, providing companies with a clear valuation to facilitate fundraising. This technology enables investors to access tailored deal flows and insights, streamlining the capital-raising process by minimizing the time spent on pitching and data aggregation.

Lace Lithography offers a Beyond‑EUV atom lithography system that uses focused neutral‑atom beams to pattern semiconductor wafers with sub‑nanometer precision, surpassing the 13.5 nm limit of traditional EUV. The platform combines high‑flux atom sources, magnetic optics, and in‑situ metrology to deliver wafer‑scale throughput compatible with existing fab lines, enabling chipmakers to continue scaling logic and memory nodes.

Latent AI provides an Efficient Inference Platform (LEIP) that enables enterprises to design, deploy, and manage AI models on edge devices with optimized performance and minimal resource consumption. This technology addresses the challenges of slow prototype development and high operational costs by facilitating rapid model retraining and real-time monitoring in the field.

The startup offers a medical application platform that enables secure recording and sharing of doctor-patient conversations, facilitating better communication and care coordination among patients and their families. By allowing healthcare providers to transcribe and review medical encounters, the platform enhances decision-making and ensures that critical information is accessible to all parties involved.

Molten Salt Solutions develops proprietary chromatography separation and mass spectrometry technologies for isotope enrichment, utilizing unique metal salt syntheses that enhance safety and reduce costs in nuclear power applications. Their platform addresses the need for efficient and reliable materials essential for advancing the next generation of nuclear energy.